- Tris Pharma's CRL for narcolepsy drug; Agenus abandons Phase 3 CRC trialPlus, news about Insilico, Ipsen, Q32 Bio, GSK’s Jemperli, Drug Farm and Padcev. ❌ FDA rejects Tris Pharma’s narcolepsy drug: Its rejection letter said that “additional information will be necess…Endpoints · 14d ago↗ source
- Biotech startup funding gap widens despite rebound in VC investment<figure><div><img src="https://imgproxy.divecdn.com/P3H5TGon7uXjRD49-L7jbsm0pv5Sbvx3i-CT1yYEXeg/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMTM5MDkwNTYwX0lGd…BioPharma Dive · 14d ago↗ source
- Deals, deals, deals; Biohaven takes on Eli Lilly; and moreWelcome back to Endpoints Weekly! Don’t miss Ryan Cross’ deep dive into the paranoia caused by competition with China. Ryan writes that US biotech companies are holding their cards close to the ...